Table 2. 10-Year event rates (95% confidence intervals) and risk reduction (95% confidence intervals) in event rate in the Russian hypertensive population by SBP control rate scenario.

	MACE	Cerebro-vascular event diagnosis	MI diagnosis	CHD death	Cerebro-vascular (stroke) death	CVD death	Life expectancy, years
Current care, 23.9% SBP control	0.294 (0.291–0.297)	0.143 (0.140–0.145)	0.048 (0.046–0.049)	0.130 (0.128–0.132)	0.090 (0.088–0.092)	0.208 (0.205–0.210)	15.94
Absolute risk reduction
Absolute difference of current care from:
40% SBP control rate	−0.038 (−0.042–−0.034)	−0.021 (−0.024–−0.018)	−0.007 (−0.009–−0.005)	−0.019 (−0.022–−0.016)	−0.011 (−0.014–−0.008)	−0.027 (−0.031–−0.024)	+0.93
60% SBP control rate	−0.085 (−0.089–−0.081)	−0.047 (−0.050–−0.044)	−0.015 (−0.017–−0.013)	−0.042 (−0.045–−0.039)	−0.025 (−0.028–−0.022)	−0.061 (−0.065–−0.058)	+2.09
Relative risk reduction
Relative risk reduction with respect to current care from:
40% SBP control rate	12.9 (11.6–14.2)	14.6 (12.5–16.7)	14.2 (10.3–18.1)	14.5 (12.3–16.7)	12.4 (9.6–15.2)	13.2 (11.5–14.8)	–
60% SBP control rate	28.9 (27.8–30.1)	32.8 (31.0–34.6)	31.8 (28.5–35.1)	32.4 (30.6–34.3)	27.9 (25.4–30.3)	29.6 (28.1–31.0)	–

CHD, coronary heart disease; CVD, cardiovascular disease; MACE, major adverse cardiac event; MI, myocardial infarction; SBP, systolic blood pressure.